Learn More
Invitrogen™ Phospho-EIF2S1 (Ser52) Polyclonal Antibody

Description
Keep as concentrated solution. Positive Control: 293T, 293T (25 μg/ml anisomycin treatment for 16hr), HeLa, HeLa (4 μg/ml Tunicamycin treatment for 16hr), HepG2, HepG2 (3 μM Thapsigargin treatment for 12 hr), PC-12 (300 μM Thapsigargin treatment for 8hr). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
Specifications
Specifications
| Antigen | Phospho-EIF2S1 (Ser52) |
| Applications | Western Blot |
| Classification | Polyclonal |
| Concentration | 0.77 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 1% BSA, 20% glycerol and 0.025% ProClin 300; pH 7 |
| Gene | EIF2S1 |
| Gene Accession No. | P05198, P68101 |
| Gene Alias | 0910001O23Rik; 2410026C18Rik; 35kDa; EIF2; EIF-2; eIF2 alpha; eIF2 alpha subunit; EIF2A; eIF-2A; eIF2alpha; EIF-2alpha; eIF-2-alpha; EIF2S1; eif2s1b; Eukaryotic translation initiation factor 2 subunit 1; eukaryotic translation initiation factor 2 subunit 1b; eukaryotic translation initiation factor 2 subunit alpha; eukaryotic translation initiation factor 2, subunit 1 alpha; eukaryotic translation initiation factor 2, subunit 1 alpha b; eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa; eukaryotic translation initiation factor 2A; fb19d01; translation initiation factor subunit; wu:fb19d01 |
| Gene Symbols | EIF2S1 |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.